Rodolphe Fischmeister,Director of Research INSERM.1981-1982: Post-doctoral Research Fellow, Department of Physiology & Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada;1982-1983: Research Associate in Anatomy, Dept of Anatomy, Emory University, Atlanta, Georgia, USA;1983-1989: Research Associate INSERM, University Paris-Sud, Orsay, France;1989-1992: Director of Research INSERM, University Paris-Sud, Orsay, France;1992-1995: Director of Research INSERM, Head of Laboratory INSERM CJF 92-11, University Paris-Sud, Faculty of Pharmacy, Châtenay-Malabry, France;1998-2001: Head of Institute IFR75 – Signalisation et Innovation Thérapeutique, University Paris-Sud, Faculty of Pharmacy, Châtenay-Malabry, France;2003-2004: Visiting Professor, Department of Cell Biology, Emory University, Atlanta, Georgia, USA;1996-2005: Director of Research INSERM, Head of Laboratory INSERM U446, University Paris-Sud, Faculty of Pharmacy, Châtenay-Malabry, France;2006-: Director of Research INSERM, Head of Laboratory INSERM U769, University Paris-Sud, Faculty of Pharmacy, Châtenay-Malabry, France
2006-2010: Head of Institute IFR141 - Innovation Thérapeutique: du Fondamental au Médicament, University Paris-Sud, Faculty of Pharmacy, Châtenay-Malabry, France
2011-: Director of Research INSERM “Classe Exceptionnelle”;2011-: Head of the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LabEx LERMIT).
